Parabilis raises 670M in record biotech IPO, signaling renewed risk appetite in healthcare innovation 🧬 Parabilis Medicines began trading on Nasdaq under the ticker PBLS after selling 33.5 million shares at 20 USD per share, raising around 670 million USD through its IPO. The

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned